Natalie Turner

957 total citations
37 papers, 729 citations indexed

About

Natalie Turner is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Natalie Turner has authored 37 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Natalie Turner's work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and HER2/EGFR in Cancer Research (6 papers). Natalie Turner is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and HER2/EGFR in Cancer Research (6 papers). Natalie Turner collaborates with scholars based in Italy, Australia and United States. Natalie Turner's co-authors include Angelo Di Leo, Laura Biganzoli, Marta Pestrin, Luca Malorni, Francesca De Luca, Francesca Galardi, Francesca Salvianti, Pamela Pinzani, Mario Pazzagli and Ann H. Partridge and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Natalie Turner

35 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Turner Italy 12 447 304 218 139 69 37 729
N. Malamos Greece 15 649 1.5× 343 1.1× 138 0.6× 212 1.5× 38 0.6× 32 864
Claudia Andreetta Italy 16 517 1.2× 296 1.0× 162 0.7× 205 1.5× 27 0.4× 41 831
Concetta Elisa Onesti Italy 16 465 1.0× 255 0.8× 334 1.5× 287 2.1× 38 0.6× 58 937
G. T. Budd United States 11 710 1.6× 346 1.1× 278 1.3× 192 1.4× 38 0.6× 20 1.1k
Roberta Maltoni Italy 21 722 1.6× 376 1.2× 338 1.6× 299 2.2× 69 1.0× 84 1.2k
Zakaria Einbeigi Sweden 18 457 1.0× 372 1.2× 360 1.7× 189 1.4× 55 0.8× 54 1.0k
Hongjian Yang China 14 282 0.6× 230 0.8× 138 0.6× 91 0.7× 88 1.3× 59 635
Davide Lombardi Italy 17 609 1.4× 211 0.7× 210 1.0× 308 2.2× 30 0.4× 57 1.0k
Luíz Henrique Gebrim Brazil 15 251 0.6× 206 0.7× 147 0.7× 66 0.5× 101 1.5× 92 735
Shona Nag India 13 720 1.6× 217 0.7× 228 1.0× 228 1.6× 26 0.4× 34 1.0k

Countries citing papers authored by Natalie Turner

Since Specialization
Citations

This map shows the geographic impact of Natalie Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Turner more than expected).

Fields of papers citing papers by Natalie Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Turner. The network helps show where Natalie Turner may publish in the future.

Co-authorship network of co-authors of Natalie Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Turner. A scholar is included among the top collaborators of Natalie Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Turner. Natalie Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Natalie, et al.. (2024). How to create accessible research summaries for the developmental language disorder community. International Journal of Language & Communication Disorders. 60(1). e13142–e13142. 2 indexed citations
2.
Seligman, Laura D., Andrew L. Geers, Keenan A. Pituch, et al.. (2023). Study protocol of an investigation of attention and prediction error as mechanisms of action for latent inhibition of dental fear in humans. BMC Psychology. 11(1). 23–23. 1 indexed citations
3.
Foley, Bridget C., et al.. (2023). “It Goes Hand in Hand with Us Trying to Get More Kids to Play” Stakeholder Experiences in a Sport and Active Recreation Voucher Program. International Journal of Environmental Research and Public Health. 20(5). 4081–4081.
4.
Morrow, Ellen, et al.. (2022). Repairing small type I hiatal hernias at the time of RYGB is not necessary to achieve resolution of reflux symptoms. Surgical Endoscopy. 37(6). 4910–4916. 3 indexed citations
5.
Stephens, Deborah M., Ying Huang, Akwasi Agyeman, et al.. (2019). Selinexor Combined with Ibrutinib Demonstrates Tolerability and Efficacy in Advanced B-Cell Malignancies: A Phase I Study. Blood. 134(Supplement_1). 4310–4310. 4 indexed citations
6.
Turner, Natalie, et al.. (2016). Docetaxel-Related Toxic Optic Neuropathy in Management of Prostate Adenocarcinoma. Clinical Genitourinary Cancer. 15(1). e115–e118. 3 indexed citations
7.
Andrews, Miles C., Natalie Turner, Andrew W. Roberts, et al.. (2015). Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma. Clinical Cancer Research. 21(23). 5222–5234. 3 indexed citations
8.
Turner, Natalie, Mattia Forcato, Simona Nuzzo, et al.. (2015). A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer. npj Breast Cancer. 1(1). 15003–15003. 2 indexed citations
9.
Turner, Natalie, Ben Tran, Hui‐Li Wong, et al.. (2015). Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival. Clinical Colorectal Cancer. 14(3). 185–191. 39 indexed citations
10.
11.
Pestrin, Marta, Francesca Salvianti, Francesca Galardi, et al.. (2014). Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Molecular Oncology. 9(4). 749–757. 135 indexed citations
12.
Andrews, Miles C., et al.. (2014). A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme. Melanoma Research. 24(2). 144–149. 5 indexed citations
13.
Turner, Natalie, Mattia Forcato, Simona Nuzzo, et al.. (2014). In silico analysis of a multifactorial consensus signature (ConSig) for predicting response to anthracycline (A)-based neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients (pts).. Journal of Clinical Oncology. 32(15_suppl). 1025–1025. 1 indexed citations
14.
Turner, Natalie, Laura Biganzoli, Luca Malorni, et al.. (2013). Adjuvant Chemotherapy: Which Patient? What Regimen?. American Society of Clinical Oncology Educational Book. 3–8. 2 indexed citations
15.
Turner, Natalie, Laura Biganzoli, Luca Malorni, et al.. (2013). The continued evidence from overviews: What is the clinical utility?. The Breast. 22. S8–S11. 1 indexed citations
16.
Turner, Natalie, Erica Moretti, Ilenia Migliaccio, et al.. (2013). Targeting triple negative breast cancer: Is p53 the answer?. Cancer Treatment Reviews. 39(5). 541–550. 106 indexed citations
17.
Turner, Natalie & Angelo Di Leo. (2013). HER2 discordance between primary and metastatic breast cancer: Assessing the clinical impact. Cancer Treatment Reviews. 39(8). 947–957. 58 indexed citations
18.
Turner, Natalie, et al.. (2013). Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Annals of Oncology. 24(9). 2224–2235. 65 indexed citations
20.
Davidson, Simon, et al.. (2010). Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency. Blood Coagulation & Fibrinolysis. 21(7). 707–708. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026